Hims & Hers Health (HIMS) EBT Margin (2020 - 2026)

Hims & Hers Health (HIMS) reported EBT Margin of 16.7% for Q1 2026, down 2702.0% on a YoY basis from 0.64% in Q1 2025, and down 662.16% sequentially from 2.97% in Q4 2025.

Hims & Hers Health (HIMS) EBT Margin (2020 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 7 years of EBT Margin data on file, last reported at 16.7% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 2702.0% year-over-year to 16.7%; the trailing twelve-month figure through Mar 2026 stood at 1.61% (down 832.0% YoY), and the FY2025 full-year result was 5.28%, up 42.0% from the prior year.
  • EBT Margin slipped to 16.7% in Q1 2026, from 2.97% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 10.32% in Q1 2025 to a low of 17.32% in Q2 2022.
  • A 5-year average of 2.33% and a median of 0.89% in 2023 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin soared 8214 bps in 2022 and slumped 2702 bps in 2026, its largest moves.
  • Tracing HIMS's EBT Margin over 5 years: stood at 6.6% in 2022, then jumped by 114 bps to 0.89% in 2023, then soared by 420 bps to 4.63% in 2024, then slumped by 36 bps to 2.97% in 2025, then slumped by 662 bps to 16.7% in 2026.
  • Business Quant data shows HIMS's EBT Margin at 16.7% in Q1 2026, 2.97% in Q4 2025, and 2.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 10.97%
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 40.73%
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 6.35%
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn -16.70%

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.70%
Dec 31, 2025 2.97%
Sep 30, 2025 2.04%
Jun 30, 2025 6.03%
Mar 31, 2025 10.32%
Dec 31, 2024 4.63%
Sep 30, 2024 5.88%
Jun 30, 2024 4.25%
Mar 31, 2024 4.46%
Dec 31, 2023 0.89%
Sep 30, 2023 -3.05%
Jun 30, 2023 -3.45%
Mar 31, 2023 -5.07%
Dec 31, 2022 -6.60%
Sep 30, 2022 -13.02%
Jun 30, 2022 -17.32%
Mar 31, 2022 -15.95%
Dec 31, 2021 -36.89%
Sep 30, 2021 -25.77%
Jun 30, 2021 -15.03%